® Tablette Médicale Pour Les Examens Cardiaques et le Diagnostic à distance CARDIO-PAD Présenté par Mr. Arthur ZANG Fondateur et Directeur General de Himore Medical S.A
>>GENESIS OF THE PROBLEM THE HEART INTRODUCTION CARDIOVASCULAR DISEASES (CVD) MAIN HUMAN BODY ORGAN Pumps blood toother organs
>>THE PROBLEM CARDIOVASCULAR DISEASES INTRODUCTION Globally 17.3 MILLION DEATHS/YEAR 30% TOTAL MORTALITY
>>BACKGROUND CENTRAL AFRICA INTRODUCTION 1.2 Million deaths/year 22% Total Mortality CENTRAL AFRICA
>>THE SITUATION FACTORS & CONSEQUENCES INTRODUCTION CAMEROON Total Patient Cost • SOLUTION: • REMOTE MEDICAL EXAMINATIONS • Reduce CVD mortality • Improve public health I I Exams Cost + Transport + Housing Lessthan40 CARDIOLOGISTS for More Than20 MILLIONS PEOPLE
OBJECTIVES SOLUTION • Perform ECG examinations in district hospitals • modest budget, located in rural areas, no specialist cardiologist Reduce risks and costs for patientsLimited time and money Facilitate the work of cardiologists Remote interpretation and computer-assisted diagnosis , mobility in the workplace, better monitoring of patients Management of biomedical data Large Scale, treatment, and remote access of data • SOLUTION • LOCAL LEVEL • GLOBAL LEVEL
>>THE SOLUTION THE CARDIO-PAD Functionalities Perform ECG examinations for patients Hospital RecordingCardiac exams withthe Cardio-pad, Medicaltouchtablet • Transmit exams to remotecardiologists Intuitive user interface to help cardiologistsmaketheirdiagnosis Information storage and management of ECG exam notifications Remote monitoring of patients
>>CARDIOGLOB SOLUTION ARCHITECTURE
CARDIOPAD TESTING RESULTS 2009-2010 GENESIS Prof. Samuel Kingué Cardiologist, medical science department of yaoundé Prof. Claude Tangha Polytechnic high school Yaoundé Prof. Pierre Tricot Polytechnic school france • Arthur Zang • Creator of Cardio-Pad OverallSuccess: 97.7%
CARDIOPAD TESTING RESULTS 2010-2011 GENESIS MASTER THESIS: CARDIOGLOB DESIGN AND DEVELOPMENT OF SYSTEM FOR ACQUISITION, PROCESSING AND TRANSMISSION USING GSM OF CARDIAC SIGNAL. Prof. Samuel Kingué et Prof. Claude Tangha 17.5 / 20
GENESE MASTER DEGREE IN SOFWARE DESIGN ENGINEERING TWO SCIENTIFIC PUBLICATIONS
AWARDS AND RECOGNITION GENESE FEBRUARY 2011 MICROSOFT SEMI-FINALISTS AT IMAGINE CUP COMPETITION NOVEMBER 2011 ORANGE TELECOM 4th Place at African Social Entrepreneur competition • CARDIO-PAD • Innovation and competition DECEMBER 2011 FING ORGANISATION Presented at “Carrefour des Possibles”
>> EXECUTION DU CHRONOGRAMME 3.B FONCTIONNALITES DU CARDIOPAD 20 juin 2012 au 30/11/2012 Fonctionnalités PadECGExam 3,6,12 Pistes PadECGScope ECGAnalyse PADTRANSMIT Transfert des données
>>ADVANTAGES OF THE SOLUTION SOLUTION CONVENTIONAL ECG DEVICES CARDIO-PAD
OURS CUSTOMERS TARGET CUSTOMERS BIG Hospitals central and generalHospitals 80 % LABORATORIES Performing examsregardless ofinterpretations District Hospitals Small rural hospitalwithoutcardiologist services
STATUS OF THE PROJECT Prototype 2011
MANUFACTURING First Tablet
MEDICAL DEVICES MANUFACTURING COMPANY HimoreMedicalfounded in 2012 in order to manufacture, commercialise and bring to market the CARDIOGLOB solution.
COMPANY BACKGROUND 7 Employees Grant Fundedwith $25,000 usd by the government of Cameroon PrivateInvestment of $5,000 Headquatered in Yaoundé, Cameroonassociatedwith the University of Yaoundé One Issued Patent Under Contractwith Public HealthMinister of Cameroon for initial implementation of Cardioglob
THE TEAM • HIMORE MEDICAL : • 3 Software Engineers • 1 BiomedicalEngineer • 2 Cardiologists • 1 Mathematician STRATEGIC PARTNERS : Microsoft, Embest, Quickembedd
30 FinishedProductsfrom first Manufacturing round
SOCIAL MEDIA MARKETING YOUTUBE FACEBOOK
>>CARDIOPAD IN THE NEWS
REVENUE MODEL
PROFIT DISTRIBUTION
Capital need • HimoreMedicalseeks$500,000 in additionalinvestment to support furthergrowth. • Capital willbedeployed as follows: • $300,000 to support manufacturing and distribution of the Cardiopad • $200,000 to support development of future products and generation of additional IP
Compellinginvestmenthighlights • Strong Patent protection • Attractive Marketopportunity and unmetneed • Positive Social Impact • ScalableTechnology • Innovativetechnologybuilt on proven and secureplatformthatreduces the investmentrisks.
Contact • Site : facebook.com/cardiopad • Email : marc_arthur 2005@yahoo.fr • Tél : (+237) 94 42 61 25
LES MEMBRES DU PROJET • ING. Arthur ZANG • Prof. Samuel KINGUE • ING. JEAN CEDRIC EVINA ONDOA • ING. JEAN PIERRE ANGUISSA ABESSOLO
CARDIO-PAD IN HOSPITAL
